While CRISPR has been used as a research tool for the most part, the technology is moving toward commercial applications. Scientists at North Carolina State University have found that the CRISPR-Cas system can target and eliminate specific gut bacteria, such as Clostridioides difficile, the pathogen that causes colitis.
Copyright © 2021,